J. Cooper

New England Journal of Medicine · 2003–2013

A researcher in the Science corpus: 7 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from J. Cooper's perspective

Ordered by how strongly the researchers J. Cooper trusts endorse each paper. Same corpus, a different order for every researcher.

1. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (New England Journal of Medicine)
2. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. (New England Journal of Medicine)
3. Nonparametric Estimation from Incomplete Observations
4. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. (Radiotherapy and Oncology)
5. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. (New England Journal of Medicine)
6. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. (New England Journal of Medicine)
7. The Statistical Analysis of Failure Time Data (Technometrics)
8. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. (Journal of Clinical Oncology)
9. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer (New England Journal of Medicine)
10. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. (Journal of Clinical Oncology)

Their papers

• Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. (2013) — 1,146 citations
• Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival (2006) — 855 citations
• Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) (2005) — 1,688 citations
• Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (2004) — 3,023 citations
• Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. (2004) — 1,011 citations
• Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. (2003) — 2,970 citations
• CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. (2003) — 669 citations